| |
著者: Michael Staun, Loris Pironi, Federico Bozzetti, Janet Baxter, Alastair Forbes, Francesca Joly, Palle Jeppesen, Jose Moreno, Xavier Hébuterne, Marek Pertkiewicz, Stefan Mühlebach, Alan Shenkin, André Van Gossum, ESPEN
雑誌名: Clin Nutr. 2009 Aug;28(4):467-79. doi: 10.1016/j.clnu.2009.04.001. Epub 2009 May 22.
Abstract/Text
Home parenteral nutrition (HPN) was introduced as a treatment modality in the early 1970s primarily for the treatment of chronic intestinal failure in patients with benign disease. The relatively low morbidity and mortality associated with HPN has encouraged its widespread use in western countries. Thus there is huge clinical experience, but there are still few controlled clinical studies of treatment effects and management of complications. The purpose of these guidelines is to highlight areas of good practice and promote the use of standardized treatment protocols between centers. The guidelines may serve as a framework for development of policies and procedures.
PMID 19464089 Clin Nutr. 2009 Aug;28(4):467-79. doi: 10.1016/j.clnu.2009.04.001. Epub 2009 May 22.
|
